Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$60.21 - $77.74 $1,324 - $1,710
22 Added 11.17%
219 $13,000
Q2 2022

Aug 02, 2022

BUY
$84.23 - $147.57 $16,593 - $29,071
197 New
197 $18,000
Q1 2022

May 10, 2022

SELL
$122.89 - $171.74 $22,611 - $31,600
-184 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$156.0 - $265.78 $4,368 - $7,441
28 Added 17.95%
184 $33,000
Q3 2021

Nov 15, 2021

BUY
$228.69 - $274.2 $33,617 - $40,307
147 Added 1633.33%
156 $40,000
Q3 2021

Nov 09, 2021

SELL
$228.69 - $274.2 $33,617 - $40,307
-147 Reduced 94.23%
9 $2,000
Q3 2019

Oct 23, 2019

BUY
$64.17 - $84.08 $2,823 - $3,699
44 Added 39.29%
156 $11,000
Q1 2018

May 02, 2018

BUY
$58.36 - $83.18 $3,443 - $4,907
59 Added 111.32%
112 $0
Q4 2017

Jan 25, 2018

BUY
$77.49 - $98.41 $1,704 - $2,165
22 Added 70.97%
53 $0
Q2 2017

Aug 14, 2017

BUY
N/A
31
31 $0

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.